Skip to main content

Table 1 Susceptibilities of E. coli to various antibiotics, concordance and kappa statistics between CLSI 2015 and EUCAST 2015 guidelines

From: Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study

Antibiotic

CLSI (%); n = 5165

EUCAST (%); n = 5165

Concordance (%)

Kappa, κ (95 % CI)

S

I

R

S

I

R

Ampicillin

13.8

0.5

85.7

13.8

0

86.2

99.5

0.985 (0.979, 0.991)

Amox-Clav

55.8

23.8

20.4

55.8

0

44.2

78.2

0.581 (0.567, 0.595)

TMP/SMX

0

0

100

0

0

100

100

1

Nitrofurantoin

84.6

11.9

3.5

96.5

0

3.5

87.6

0.351 (0.314, 0.388)

Ciprofloxacin

57.3

0.2

42.5

55.9

1.4

42.7

98.4

0.969 (0.963, 0.975)

Cefuroxime

63.7

3.5

32.8

63.7

0

36.3

96.5

0.924 (0.914, 0.934)

Gentamicin

78.5

0.2

21.3

78.1

0.4

21.5

99.5

0.979 (0.973, 0.985)

Amikacin

99.3

0.3

0.4

90.5

8.8

0.7

91.1

0.112 (0.079, 0.145)

Cefotaxime

69.7

0.4

29.9

69.7

0.4

29.9

100

1

Ceftazidime

76.3

0.9

22.8

71.5

4.8

23.7

93.7

0.859 (0.843, 0.85)

Ceftriaxone

67.7

0.1

32.2

67.7

0.1

32.2

100

1

Cefepime

80.5

10.0

9.5

72.9

9.8

17.3

84.9

0.600 (0.578, 0.622)

Meropenem

99.7

0.1

0.2

99.8

0.1

0.1

99.7

0.724 (0.573, 0.875)

  1. Amox-Clav amoxicillin–clavulanate, TMP/SMX trimethoprim–sulfamethoxazole, S susceptible, I intermediate, R resistant